Joseph DiBrino
Pfizer (United States)(US)
Publications by Year
Research Areas
Neurotransmitter Receptor Influence on Behavior, Cannabis and Cannabinoid Research, Cancer therapeutics and mechanisms, Growth Hormone and Insulin-like Growth Factors, Chemical Synthesis and Analysis
Most-Cited Works
- → Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.(1988)238 cited
- → Discovery of 1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide Hydrochloride (CP-945,598), a Novel, Potent, and Selective Cannabinoid Type 1 Receptor Antagonist(2008)62 cited
- → Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs)(2003)47 cited
- → New bicyclic cannabinoid receptor-1 (CB1-R) antagonists(2005)42 cited
- → Discovery and biological characterization of capromorelin analogues with extended half-lives(2002)29 cited
- → Design and synthesis of novel FKBP inhibitors(1992)28 cited
- → Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity(2008)24 cited
- → Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors(2012)17 cited
- → Structure elucidation of a new neutral macrolide antibiotic(1986)16 cited
- → trans-3-Benzyl-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor(1998)11 cited